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Our previous studies have shown that adult BALB/c mice given total lymphoid 
irradiation  (TLI)  1  (17  fractions  of  200  rad  each)  will  accept  H-2-incompatible 
allogeneic  bone  marrow  grafts  without  the  development  of graft-vs.-host  disease 
(1-8).  The  resultant  chimeras  are  specifically tolerant  of tissues  derived  from  the 
marrow donor strain, but promptly reject  tissues from third-party strains  (1,  3-7). 
Similarly, newborn mice will accept allogeneic bone marrow grafts without graft-vs.- 
host disease, and become specifically tolerant to the tissues of the marrow donor (9, 
10). Spleen cells  from both adult  mice given TLI  (11) and newborn mice (12,  13) 
contain nonspecific suppressor cells of the mixed leukocyte reaction  (MLR)  before 
marrow transplantation. Recent evidence suggests that after transplantation of allo- 
geneic or semiallogeneic lymphoid cells, both TLI-treated adult mice (14,  15)  and 
newborn mice (16) or rats (17-22)  develop suppressor cells of transplantation immu- 
nity which are specific for the tolerizing tissue antigens. 
The object of the present  investigation was  to examine in detail the regulatory 
activity of spleen cells from both TLI-treated and newborn  mice in the MLR as 
judged by DNA synthesis, and the generation of cytolytic and suppressor cells.  The 
experimental results suggest that spleen cells from both sources inhibit DNA synthesis 
and the generation of cytolytic cells regardless of the strain of origin of the responder 
and  stimulator  cells.  However,  the  spleen  cells  do  not  inhibit  the  generation  of 
antigen-specific suppressor cells. Thus, blocking of the cytolytic arm of the allogeneic 
response without blocking of the suppressor arm in vitro may provide a model system 
for tolerance induction and maintenance in  vivo in TLI-treated or newborn  mice 
given allogeneic bone marrow cells. 
* Supported by grant AI-11313 from the National Institutes of Health, and by the Howard Hughes 
Medical Institute. 
1  Abbreviations used in  this paper:  CML, cell-mediated lympholysis;  FCS, fetal  calf serum;  MLR, 
mixed leukocyte reaction; NK, natural killer; TLI, total lymphoid irradiation. 
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Materials  and  Methods 
Mice.  Male BALB/c (H-2a), C57BL/Ka (H-2b), and C3H/Km  (H-2  k) mice were obtained 
from  the specific pathogen-free colony of Dr.  Robert  Kallman, Department  of Radiology, 
Stanford University School of Medicine. Adult mice used for experimentation were between 
the ages of 2 and 6 mo, and newborn mice were between the ages of 2 and 3 d. 
Radiotherapy Procedure (TLI).  4-6-mo-old BALB/c mice were anesthetized daily with pen- 
tobarbitol and positioned in an apparatus designed to irradiate the major lymphoid organs, 
including all major lymph nodes, the spleen, and the thymus, as described by Slavin et al. (23). 
The skull, lungs, tail, and hind legs were shielded with lead. The mice were given 200 rad/d, 
five times/wk, to a  total dose of 3,400  rad. Irradiation was delivered from a  single 250  kV 
(15 A) source (Phillips Medical System Inc., Shehon, CT). The dose rate was 93 rad/min using 
an 0.35-mm Cu filter and a 52-cm source-axis distance. Tetracycline was added to the drinking 
water during TLI  and  1 wk after completion of irradiation. TLI-treated mice were  killed 
between 5 and 15 d after completion of TLI in all experiments. 
Preparation of Spleen Cells.  Spleens were removed aseptically, and single-cell suspensions were 
prepared by gently pressing the spleen fragments through  a  nylon fiber mesh  (Tetko, Inc., 
Elmsford, NY). The cells were washed three times and counted in 2% acetic acid before use. 
Cell viability was determined by trypan blue dye exclusion. 
Primao~ MLR-Suppressor Assay.  Responder, stimulator, and co-cultured (putative suppressor) 
cells were cultured at a concentration of 5 X  105 cells each, in a final volume of 0.3 ml/well, 
using 96-well flat-bottomed mieroculture plates (3596;  Costar, Data Packaging, Cambridge, 
MA). The cells were cultured in RPMI 1640 medium supplemented with 25 mM Hepes, 2 mM 
glutamine, 100 U/ml penicillin, 100/~g/ml streptomycin (all from Grand Island Biological Co., 
Grand  Island, NY),  5  ×  10  -s M  2-mercaptoethanol, and  5%  pooled human  serum  (MLR 
medium). Human serum was a  kind gift of Dr. Edgar Engleman, Department of Pathology, 
Stanford University School of Medicine. Stimulator and co-cultured cells were treated with 
3,000  and  1,500  rad,  respectively, from  a  137Ce source  (Mark  1 model  25  irradiator; J.  L. 
Shepherd and Associates, Glendale, CA) and washed once just before culture. 
Cultures were incubated at 37°C in a humidified atmosphere of 5% CO2 in air. After 96 h, 
1/~Ci of [aH]thymidine (sp act 6.7 Ci/mM; New England Nuclear, Boston, MA) was added to 
each well. 18 h later, cells were harvested onto glass fiber filter paper (Whatman Inc., Chemical 
Separation  Div.,  Clifton,  N  J)  using  a  multiple automated  sample  harvester  (Bio-Plastics, 
Redwood City, CA). The  dried paper disks were placed into  mini-vials containing  2.5  ml 
scintillation cocktail (Betafluor, National Diagnostics, Somerville, N  J)  and the incorporated 
radioactivity was  measured  in  a  liquid  scintillation counter  (Beckman  Instruments,  Inc., 
Fullerton, CA). 
Data shown for all MLR cultures are the mean counts per minute of triplicate assays with 
the standard deviation of the mean. The following formula was used to calculate suppression: 
percent suppression -- (1 -  [(cpm with co-cultured cells from TLI-treated mice)/(cpm with co- 
cultured cells from normal mice)]) ×  100. 
Prima~y Cell-mediated Lympholysis (CML)-Suppressor Assay 
PREPARATION OV  ~FVECTOR CELLS.  Responder  cells  (5  ×  l0  s)  were  cultured  with  equal 
numbers of stimulator and co-cultured cells as described in the previous section. On day 5, 
effector cells were harvested and washed once. Cells were resuspended to desired concentrations 
in CML medium after counting in 0.04%  trypan blue. CML medium was similar to MLR 
medium except that  10%  fetal calf serum  (FCS)  (Grand Island Biological Co.)  was used  in 
place of 5% pooled human serum. 
In control cultures (co-cultured cells obtained from normal BALB/c donors), cell recovery at 
the end of 5 d was 80-140% of the number of responder cells added initially, and cell viability 
was 60-90%. There were no consistent differences in the recovery and viability of cells in the six 
different allogeneic combinations studied. 
PREPARATION OF TARGET CELLS.  P815 (DBA/2, H-2  d) mastocytoma, EL-4 (C57BL/6, H-2  b) 
lymphoma, and  BW5147  (AKR, H-2  k)  thymoma lines were a  gift of Dr.  Irving Weissman, 
Department of Pathology, Stanford University School of Medicine. Cells were maintained at 
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the  cells  were  passaged  and  fresh  medium added.  2  ×  106  tumor cells  were  washed  and 
resuspended in 0.4 ml RPMI  1640 with 5% FCS and 100/~Ci  (51Cr) sodium chromate (New 
England Nuclear). Cells were incubated at 37°C for 90 min in a CO2 incubator with occasional 
agitation. After incubation, target cells were washed four times and adjusted to a concentration 
of 1 ×  105 cells/ml in CML medium. 1 ×  104 P815, EL-4, and BW5147 cells incorporated 0.6- 
0.9 ×  104 cpm, 0.7-1.1 ×  104 cpm, and 0.5-0.7 ×  104 cpm, respectively. 
5LCR RELEASE ASSAY.  Effector cells and target cells were combined in 96-well V-bottomed 
microtiter plates  (001-010-2701;  Dynatech Laboratories, Inc., Dynatech Corp.,  Alexandria, 
VA)  in a  final volume of 0.2 ml. Before  incubation for 6 h  at 37°C, the plates were lightly 
centrifuged (100 g,  1 min). At the end of the incubation period, the plates were centrifuged 
(400 g, 5 min) again. An aliquot of the supernatant (100 #1) was removed, and radioactivity 
was measured in a gamma counter (Biogamma II, Beckman Instruments, Inc.). Spontaneous 
release  of 51Cr was obtained by monitoring radioactivity released during the incubation of 
1 ×  104 target cells alone. Maximum release of SICr was determined by monitoring  radioactivity 
released  after three rapid cycles of freezing and thawing of labeled target cells suspended in 
water. This generally released 90% of total radioactivity incorporated in all ceils. The range of 
spontaneous release of the 51Cr-labeled P815, EL-4, and BW5147 after a 6-h incubation was 9- 
17%, 7-13%,  and 5-8% of maximum release  in all experiments, respectively. Percent specific 
lysis was calculated according to the formula: percent specific  lysis =  ([cpm experimental - 
cpm spontaneous release]/[cpm maximum release  -  cpm spontaneous release])  ×  100. 
The standard deviation of the mean cpm of triplicate assays used to calculate the percent 
specific  lysis was  usually <5% of the mean value. The data are expressed  as lyric units per 
culture (24). One lytic unit is defined as the number of effector  cells required to achieve 30% 
specific lysis. The number of lyric units per culture was determined by adding graded volumes 
obtained from the MLR cultures to the target cells. A curve was constructed to determine the 
volume of cells producing 30% specific lysis, and calculations were made by setting that volume 
equal to  one lytic unit. The following formula was Used to  calculate suppression: percent 
suppression =  (1  -  [(lyric units/culture with co-cultured cells from TLI-treated mice)/(lytic 
units/culture with co-cultured cells from normal mice)I)  ×  100. 
Secondary MLR-Suppressor Assay.  Primary bulk MLR cultures (2 ml total volume, with 3 × 
106 responder, stimulator, and co-cultured cells  each)  were set  up in 24-well  flat-bottomed 
culture plates  (3524;  Costar).  A  fixed  aliquot  (133 /tl)  of cells  was  harvested  after  6  d  of 
incubation and washed once in medium. These were used as co-cultured cells in the secondary 
MLR after irradiation in vitro (1,500 tad). Fresh responder cells (5 ×  105) and an equal number 
of fresh stimulator cells were cultured with the aliquot of cells from the primary culture in 0.3 
ml of MLR medium in microculture plates. Secondary MLR cultures without co-cultured cells 
were also set up as controls. Thereafter, [SH]thymidine  incorporation was measured as described 
in the primary MLR-suppressor assay.  Percent suppression was calculated by the formula: 
percent suppression =  (1  -  [(epm with co-cultured eells)/(cpm without co-cultured cells)])  × 
100. 
Secondary CML-Suppressor Assay.  Cultures  were  set  up  in  the  identical  manner to  the 
secondary MLR-suppressor assay.  Effector cells were harvested after 5 d  of culture and the 
number of lytic units per culture was measured as described in the primary CML-suppressor 
assay.  Percent suppression was calculated by the formula: percent suppression =  (1  -  [(lytic 
units/culture with co-cultured cells)/(lytic units/culture without co-cultured cells)]) ×  100. 
Results 
Nonspecific Inhibition of [aH] Thymidine Incorporation in the Prima~y MLR by TLI-treated 
BALB/c Spleen Cells.  In several experiments, spleen cells from TLI-treated BALB/c 
mice were co-cultured with equal numbers of responder and stimulator cells from a 
variety of strains. Co-cultured cells were given 1,500 rad in vitro  just before incubation. 
Similarly treated spleen cells from normal (unirradiated) BALB/c mice were used as 
co-cultured cell controls. One representative experiment (four experiments performed) 
is  shown  in  Table  I.  Spleen  cells  obtained  from  mice  between  5  and  15  d  after SHIGEKI OKADA AND SAMUEL STROBER 
TABLE  I 
Nonspecific Inhibition of the MLR by Spleen Cells  fiom Donors Given TLI 
Co-cul-  [8H]Thymidine in-  Percent[] 
Responder  Stimulator  tured  corporation (mean 
cells*  cells:[:  cells§  epm ±  SD)  suppression 
BALB  BALB  BALB  6,637 ±  581 
BALB  C57  BALB  119,165  ±  4,951 
BALB  C57  TLI¶  27,787 ±  2,835  76.7 
C57  C57  C57  2,132 ±  229 
C57  BALB  BALB  79,170 ±  5,529 
C57  BALB  TLI  14,581 ±  3,015  81.6 
C3H  C3H  C3H  3,540 ±  1,447 
C3H  C57  BALB  133,372  ±  6,482 
C3H  C57  TLI  12,298 ±  2,676  90.8 
BALB  BALB  BALB  6,673 +  581 
BALB  C3H  BALB  45,782 ±  687 
BALB  C3H  TLI  12,070 ±  3,560  73.6 
C57  C57  C57  2,132 ±  229 
C57  C3H  BALB  62,863 ±  2,825 
C57  C3H  TLI  9,056 ±  1,388  85.6 
C3H  C3H  C3H  3,540 +  1,447 
C3H  BALB  BALB  103,678  ±  8,145 
C3H  BALB  TLI  24,243 ±  1,366  76.6 
* 5 ×  10  s responder cells per well were used. BALB, C3H, C57 indicate spleen 
cells  from normal  BALB/c, C3H/Km, and  C57BL/Ka donor strains,  re- 
spectively. 
~: 5 ×  105 stimulator cells per well were given 3,000 rad in vitro. 
§ 5 ×  105 co-cultured cells per well were given 1,500 rad in vitro. 
I[ Percent suppression  =  (1  -  [(cpm  with TLI co-cultured cells)/(cpm with 
BALB co-cultured cells)]) ×  100. 
¶ TLI-treated BALB/c donors;  other donors were untreated adult mice. 
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completion of TLI suppressed  the MLR  by 55-95% with a  mean  of 77% as compared 
with  control  cultures  with  cells  from  normal  mice.  There  was  no  specificity  for 
responder or stimulator cells in any strain combination  used in these experiments. 
Nonspecific Inhibition of the Generation of Cytolytic Cells in the Prima~y MLR by TLI-treated 
BALB/c Spleen Cells.  As shown  in Table  II, TLI-treated  spleen cells suppressed  the 
generation of alloantigen-specific cytolytic cells as measured by lytic units per culture. 
The suppressor  activity was also nonspecific and  varied from 50 to 90% with a  mean 
of 73%  in  four different  experiments.  In simultaneous  MLR  and  CML  experiments 
using  the  same  surce  of  TLI-treated  spleen  cells,  the  degree  of  suppression  was 
generally within  10-15%  agreement. 
Generation of Antigen-specific Suppressor Cells in the Prima~y Bulk MLR (BALB Responder 
Cells)  After  the  Addition  of  TLI-treated  Spleen Cells.  Putative  suppressor  cells  were 
generated  in  the primary  bulk  MLR  consisting of BALB/e  responder  cells, C57BL/ 
Ka stimulator  cells (3,000  rad),  and  co-cultured cells (1,500  rad)  from either normal 
or  TLI-treated  BALB/c  donors  at  a  concentration  of 3  ×  106  cells  each  per  well. 526  SUPPRESSOR  CELLS  AFTER TOTAL LYMPHOID  IRRADIATION 
TABLE II 
Nonspecific Inhibition of the Generation of Cytolytic Cells in the MLR by Spleen Cells 
from Donors Given TLI 
MLR* 
Responder  Stimulator cells  Co-cultured 
cells  cells 
CML assay target  Lytic units/  Percent 
cell  eulture~  suppression§ 
BALB  C57  BALB  EL-4  444.4 
BALB  C57  TLI  EL-4  178.6  59.8 
C57  BALB  BALB  P815  227.3 
C57  BALB  TLI  P815  26.7  88.3 
C57  C3H  BALB  BW5147  55.6 
C57  C3H  TLI  BW5147  <12.5  >77.5 
BALB  C3H  BALB  BW5147  149.3 
BALB  C3H  TLI  BW5147  66.7  55.3 
C3H  BALB  BALB  P815  294.1 
C3H  BALB  TLI  P815  106.4  63.8 
C3H  C57  BALB  EL-4  135.1 
C3H  C57  TLI  EL-4  <25.0  >81.5 
* 5 ×  10  s responder, stimulator, and co-cultured cells per well were used in each MLR culture. 
Calculation for lyric units per culture is explained in Materials and Methods. 
§ Percent suppression -- (1  -  [(lytic units/culture with TLI co-cultured  cells)/(lytic units/culture with 
BALB co-cultured cells)]) ×  100. 
Additional control MLR cultures containing BALB/c responders, BALB/c stimulator, 
and either normal or TLI-treated BALB/c co-cultured cells were simultaneously set 
up. On day 6, cells from a  fixed volume (133/~1)  of each primary bulk MLR  culture 
were added to a  fresh micro MLR  (secondary MLR)  as co-cultured cells. Cells from 
primary  cultures  were  irradiated  in  vitro  (1,500  rad)  before  transfer.  Suppressor 
activity generated in the primary bulk MLR  was always expressed in comparison to 
[3H]thymidine incorporation in a  secondary MLR  culture without  co-cultured cells. 
Results  of  these  experiments  are  shown  in  Table  III.  Experiments  1  and  2  are 
representative of nine and three experiments, respectively. TLI-treated BALB/c spleen 
cells used  in these experiments had  shown  >50%  suppression  in  the primary MLR 
and CML-suppressor assays. 
When cells from syngeneic primary cultures  (BALB  ×  BALB  ×  BALB, or BALB 
×  BALB  ×  TLI)  were added to the secondary MLR,  slight suppression  (<18%)  or 
enhancement was observed in seven out of nine experiments. There was little difference 
in  the  percent  suppression  observed with  the  two  syngeneic combinations  (TLI  vs. 
BALB  co-cultured  cells).  Therefore,  nonspecific  suppressor  activity of TLI-treated 
BALB/c spleen cells (Table I) did not  persist in culture with syngeneic cells. When 
cells from BALB ×  C57 ×  BALB primary cultures were added to the secondary MLR 
(experiments  1 and 2), marked suppression (mean, 85.6%)  was observed regardless of 
the  strain  of origin  of the  secondary  responder  or  stimulator cells  (range,  43-97% 
suppression)  (Table III). On  the other hand,  when  cells from  BALB  ×  C57  X  TLI 
primary cultures were added to the secondary MLR, marked suppression was observed SHIGEKI  OKADA  AND  SAMUEL  STROBER  527 
TABLE III 
Generation of Antigen-specific Suppressor Cells in the Bulk MLR (BALB X  C57) after Addition of 
Spleen Cells  from Donors Given TLI: Seconda(y MLR Assay System 
Secondary MLR  [aH]Thymidine  Percent 
Stimulator  Co-cultured cells  incorporation  suppression]] 
Responder cells*  cells~  (primary culture)§  (mean cpm ±  SD) 
Experiment 1 
BALB  BALB  7,114 ±  566 
BALB  C57  114,829 ±  7,263 
BALB  C57  BALB X BALB ×  BALB  100,526 ±  14,204  12.5 
BALB  C57  BALB x  BALB ×  TLI  105,054 ±  6,662  8.5 
BALB  C57  BALB ×  C57 X BALB  7,842 ±  1,284  93.2 
BALB  C57  BALB X C57 X TLI  26,580  ±  3,361  ]76.9] 
BALB  BALB  7,114 ±  566 
BALB  C3H  126,303 ±  14,563 
BALB  C3H  BALB ×  BALB X BALB  155,176 ±  5,746  -22.9 
BALB  C3H  BALB ×  BALB ×  TLI  104,394 ±  16,273  17.3 
BALB  C3H  BALB ×  C57 X BALB  18,203 ±  2,838  85.6 
BALB  C3H  BALB ×  C57 ×  TLI  97,340  ±  11,517 
Experiment 2 
C3H  C3H  5,315 ±  811 
C3H  C57  72,450 ±  5,629 
C3H  C57  BALB X BALB X BALB  85,366  ±  8,640  -17.8 
C3H  C57  BALB X BALB x  TLI  74,255 ±  10,159  -2.5 
C3H  C57  BALB X C57 X BALB  10,256 ±  1,664  85.8 
C3H  C57  BALB ×  C57 X TLI  14,204 ±  1,070  [-~ 
C3H  C3H  5,315 ±  511 
C3H  BALB  65,101  ±  7,259 
C3H  BALB  BALB ×  BALB x  BALB  100,737 ±  6,491  -54.7 
C3H  BALB  BALB X BALB ×  TLI  83,362  ±  10,225  -28.1 
C3H  BALB  BALB x  C57 x  BALB  10,332 ±  1,982  84.1 
C3H  BALB  BALB ×  C57 ×  TLI  51,760  ±  2,358  [-~ 
* 5 X  106 responder cells per well were used in the secondary MLR. 
:~ 5 X  105 stimulator cells per well were given 3,000 rad in vitro. 
§ Co-cultured cells obtained from the bulk MLR culture at day 6 were given 1,500 rad. 3 X l0  s responder, 
stimulator, and co-cuhured cells used in the bulk MLR are shown. 
II Percent suppression -- (1 -  [(cpm with co-cultured cetls)/(cpm without co-cuhured cells)] x  100. 
with  C57,  but  not  with  C3H  or  BALB  stimulator  cells.  Similar  suppression  was 
observed with BALB  or C3H  responder  cells.  Thus,  suppressor activity was  antigen- 
specific, but  was not restricted by the H-2 type of the secondary responder cells as has 
been  reported  in  several  experimental  systems  (25-28).  The  magnitude  of the  sup- 
pressor  activity  using  C57  stimulators  was  81.4%  on  the  average  (range,  48-95%). 
However,  the percent suppression using BALB  or C3H  stimulators was  15.5% on the 
average  (range, -22-38%). 
Putative  suppressor  cells  from  primary  MLR  cultures  were  also  assayed  for  their 
ability  to  inhibit  the  generation  of cytolytic  cells  in  secondary  MLR  cultures.  The 
results  of  these  experiments  are  shown  in  Table  IV.  Experiments  I  and  2  are 
representative  of  seven  and  three  experiments,  respectively.  TLI-treated  BALB/c 528  SUPPRESSOR CELLS AFTER TOTAL LYMPHOID  IRRADIATION 
TABLE  IV 
Generation of Antigen-specific Suppressor Cells in the Bulk MLR (BALB ×  (257) after Addition of 
Spleen Cells  from Donors Given TLI: Secondary CML Assay System 
Secondary MLR 
Responder  Stimulator  Co-cultured cells 
cells*  cells:~  (primary culture)§ 
CML assay  Lytic units/  Percent 
target cell  culture  suppression][ 
Experiment 1 
BALB  C57  EL-4  357.1 
BALB  C57  BALB X BALB ×  BALB  EL-4  322.6  9.7 
BALB  C57  BALB ×  BALB X TLI  EL-4  327.9  8.2 
BALB  C57  BALB X C57 ×  BALB  EL-4  <50.0  >86.0 
C57  BALB × C57 × TLI  EL-4  <50.0  BALB 
BALB  C3H  BW5 t47  66.7 
BALB  C3H  BALB ×  BALB X BALB  BW5147  >100.0  -49.9 
BALB  C3H  BALB × BALB × TLI  BW5147  90.9  -36.3 
BALB  C3H  BALB X C57 ×  BALB  BW5147  <25.0  >62.5 
C3H  BALB X C57 X TLI  BW5147  56.8  BALB 
Experiment 2 
C3H  C57  EL-4  185.2 
C3H  C57  BALB x  BALB X BALB  EL-4  ND¶ 
C3H  C57  BALB × BALB × TLI  EL-4  ND 
C3H  C57  BALB × C57 ×  BALB  EL-4  <50.0  >73.0 
C3H  C57  BALB × C57 × TLI  EL-4  <50.0 
C3H  BALB  P815  277.8 
C3H  BALB  BALB × BALB ×  BALB  P815  ND 
C3H  BALB  BALB ×  BALB X TLI  P815  ND 
C3H  BALB  BALB × C57 ×  BALB  P815  125.0  55.0 
C3H  BALB  BALB × C57 × TLI  P815  208.3 
* As for Table IIL 
:~ As for Table IlL 
§ As for Table III. 
II Percent suppression  ~  (1 -- [(lytic units/culture with co-cultured cells)/(lytic units/culture without co- 
cultured cells)]) x  100. 
¶ Not done. 
spleen  cells used  in  these  experiments  had  shown  >50%  suppression  in  the  primary 
MLR  and  CML-suppressor  assays.  The  results  of  the  secondary  CML-suppressor 
assays were similar to those of the secondary MLR-suppressor  assays.  Briefly, neither 
BALB  ×  BALB  X  BALB, nor BALB  X  BALB  X  TLI  primary  culture  cells showed 
substantial  suppression  of the generation of cytolytic cells in secondary cultures.  Cells 
from  BALB  ×  C57  X  BALB  primary  cultures  inhibited  the  generation  of cytolytic 
cells  by  roughly  the  same  magnitude  in  all  secondary  responder  and  stimulator 
combinations  used with  an  average of >78.2%  suppression  (range,  55-94%).  On  the 
other hand,  cells from BALB ×  C57 X  TLI  primary cultures showed antigen-specific 
suppressor activity. The mean percent suppression was >79.7%  (range,  72-94%)  when 
C57 stimulator cells were used in the secondary MLR.  However, it was  15.2%  (range, 
-46-54%)  when  C3H  or  BALB  stimulator  cells were  used  in  the  secondary  MLR. 
Even in the experiment that showed 54% suppression  (upper limit of range of values), 
the  number  of lytic units  per secondary  culture  was  still sixfold higher using  BALB SHIGEKI OKADA AND SAMUEL STROBER  529 
X C57 X TLI primary culture cells as compared with BALB X C57 × BALB primary 
culture cells. 
It is unlikely that the specific suppression  of the MLR and CIML mediated by the 
BALB × C57 X TLI primary cells is due to specific killing of C57 stimulator cells in 
the secondary cultures. In several experiments, ~90% suppression  of the generation of 
cytolytic cells was observed in the primary cultures. At an effector/target cell ratio of 
1:4, these primary cells produced no cytolysis above background levels. Nevertheless, 
aliquots of the same primary cells produced marked specific suppression (-80%)  of 
the secondary cultures despite the fact that the ratio of the primary cells to secondary 
stimulator cells was considerably less than 1:4. 
Generation of Antigen-specific Suppressor Cells in the Pn'mary MLR (C57 Responder Cells) 
After the Addition of TLI-treated Spleen Cells.  In all of the secondary culture experiments 
described above, responder cells in the primary cultures were syngeneic (BALB) with 
the  primary  co-cultured  cells  (either  normal  or  TLI-treated  BALB).  In  further 
experiments, putative suppressor  cells were also  generated in primary bulk MLR 
cultures consisting ofC57BL/Ka responder cells, BALB/c stimulator cells (3,000 rad), 
and co-cultured cells (1,500 rad) from either normal or TLI-treated BALB/c donors. 
Suppressor  activity was tested again in both secondary MLR and CML-suppressor 
assays. 
Experiments 1 and 2 shown in Table V are representative of four experiments in 
each category. TLI-treated BALB/e spleen cells used in these experiments had shown 
>60%  suppression  in the primary MLR and CML-suppressor assays. When C57  X 
BALB  ×  BALB primary culture cells were added to the secondary MLR cultures, 
marked suppression  was observed with all combinations of secondary responders and 
stimulators. The mean percent suppression  using C57 responders was 80.4% (range, 
75-87%). The mean percent suppression  using C3H responders was 66.4%, and there 
was a wider range of values (59%, 84%, 91%, 93%, with BALB stimulators; -4%, 35%, 
80%, 93% with C57 stimulators). 
On the other hand, when C57 X BALB X TLI primary culture cells were added to 
the secondary MLR, marked suppression was only observed with C57 responders and 
BALB stimulators (mean of 70.5% suppression;  range, 54-80%).  All other secondary 
responder  and  stimulator cell  combinations showed considerably less suppression 
(mean of 11.3%; range, -17-28%). Thus, in this series of experiments, suppressor  cells 
generated in the primary MLR cultures containing TLI-treated spleen cells showed 
antigen specificity  as well  as  restriction with regard to the strain of origin of the 
responder cells. Marked suppression was observed only when the secondary responder- 
stimulator combination was identical to the primary responder-stimulator combina- 
tion. 
A similar pattern of suppression  was seen in the secondary CML-suppressor assay 
(Table VI).  Experiments  1 and  2  (Table VI)  correspond to experiments  1 and  2 
shown in Table V. A total of four experiments were performed in each category. C57 
X BALB X BALB primary culture cells nonspecifically suppressed  the generation of 
cytolytic  cells with an average of >78.1% (range, 37->96%)  in all secondary responder- 
stimulator combinations with the [aH]thymidine incorporation assay. More uniform 
values  were obtained with C57  responder cells  (mean, >82.9%  suppression;  range, 
>65->96%).  The mean percent suppression  with C3H  responder cells was  73.3% 
(range,  37-92%).  Addition of C57  X  BALB  X  TLI  primary culture cells  to  the 530  SUPPRESSOR  CELLS AFTER  TOTAL LYMPHOID  IRRADIATION 
TABLE V 
Generation of Antigen-specific Suppressor Cells in the Bulk MLR (C57 ×  BALB) after Addition of 
Spleen Cells  from Donors Given TLI: Secondary MLR Assay System 
Secondary MLR  [aH]Thymidine  Percent 
Stimulator  Co-cultured cells  incorporation  suppressionl  I 
Responder cells*  eells~:  (primary culture)§  (mean cpm ± SD) 
Experiment 1 
C57  C57  893 ± 234 
C57  BALB  27,346 ± 3,689 
C57  BALB  C57 X BALB X BALB  6,032 :J: 843  77.9 
C57  BALB  C57 × BALB X TLI  7,775 +  1,523  [YT-.g] 
C57  C57  893 ± 234 
C57  C3H  21,779 ± 3,517 
C57  C3H  C57 x  BALB x BALB  3,541 ± 462  83.7 
C57  C3H  C57 X BALB × TLI  15,836 ± 3,293 
Experiment 2 
C3H  C3H  5,2% ± 876 
C3H  BALB  102,679 ±  13,753 
C3H  BALB  C57 x BALB X BALB  7,197 ±  1,185  93.0 
C3H  BALB  C57 x BALB × TLI  74,106 ±  1,150 
C3H  C3H  5,296 ± 876 
C3H  C57  126,456 ±  1,465 
C3H  C57  C57 × BALB x BALB  8,593 ± 2,124  93.2 
C3H  C57  C57 × BALB X TLI  115,273 :t: 2,162 
* 5 X 10  s responder cells per well were used. 
5 ×  10  s stimulator cells per well were given 3,000 rad in vitro. 
§ Co-cultured cells were obtained from the bulk MLR at day 6 and given 1,500 rad in vitro. 3 X 10  s 
responder, stimulator, and co-cultured cells used in the bulk MLR are shown. 
II As for Table III. 
secondary MLR cultures again showed marked suppression only with secondary C57 
responder cells and BALB  stimulator cells  (mean, >83.7%  suppression; range,  75- 
>89%). Minimal suppression was seen in Other combinations (mean,  12.4% suppres- 
sion; range, -29-62%). Even in the experiment that showed 62% suppression (upper 
limit of range of values), the number of lytic units per secondary culture was  still 
ninefold higher using C57  ×  BALB  X  TLI primary culture cells as compared with 
C57 X  BALB ×  BALB primary culture cells. Thus, suppression of the generation of 
cytolytic cells in the secondary MLR was antigen-specific, and restricted by the strain 
of origin of the  secondary  responder  cell.  This  pattern  of suppression  cannot  be 
explained by specific killing of secondary stimulator cells by cytolytic cells generated 
in primary cultures, because  destruction of stimulator cells  should have  produced 
suppression of the secondary MLR  and CML assays regardless of the origin of the 
responder cells. 
Correlation between the Degree of Nonspecific Suppression of Primary MLR Cultures and the 
Degree of Specificity of Suppression in Secondary MLR Cultures.  The ability of spleen cells 
from donors given TLI to suppress the primary MLR with BALB responder and C57 
stimulator cells was tested in 27 different experiments. In 24 experiments, nonspecific 
suppression of [aH]thymidine incorporation or generation of cytolytic cells was at least SHIGEKI OKADA AND SAMUEL STROBER  531 
TABLE VI 
Generation of Antigen-specific Suppressor Cells in the Bulk MLR (C57 ×  BALB) after Addition of 
Spleen Cells  fiom Donors Given TLL" Secondary CML Assay System 
Secondary MLR 
Responder  Stimulator  Co-cultured cells 
cells*  cells~  (primary culture)§ 
CML assay  Lytic units/  Percent 
target cell  culture  suppressionll 
Experiment  1 
C57  BALB  P8 ! 5  203.0 
C57  BALB  C57 X BALB X BALB  P815  <25.0  >87.7 
C57  BALB  C57 X BALB X TLI  P815  <25.0 
C57  C3H  BW5147  55.6 
C57  C3H  C57 x  BALB x  BALB  BW5147  <12.5  >77.5 
C57  C3H  C57 × BALB x TLI  BW5147  47.6 
Experiment  2 
C3H  BALB  P815  312.5 
C3H  BALB  C57 X BALB x  BALB  P815  <12.5  >96.0 
C3H  BALB  C57 X BALB X TLI  P815  119.0 
I  I 
C3H  C57  EL-4  451.9 
C3H  C57  C57 × BALB × BALB  EL-4  <25.0  >94.5 
C3H  C57  C57 × BALB × TLI  EL-4  342.1 
* As for Table III. 
:~ As for Table III. 
§ As for Table III. 
It As for Table IV. 
50%,  however,  in  three experiments, <50%  suppression was  observed.  In  the  latter 
experiments,  there  appeared  to  be  a  correlation  between  the  degree  of nonspecific 
suppression in the primary cultures and the degree of antigen specificity of suppression 
in  the  secondary  cultures.  The  degree  of antigen  specificity can  be  taken  as  the 
difference in the percent suppression using secondary stimulator cells syngeneic to the 
primary stimulator cells, and that  using secondary stimulator cells allogeneic to the 
primary stimulator cells (i.e., percent suppression with secondary C57 stimulator cells 
minus the percent suppression with secondary C3H or BALB stimulator cells). When 
the percent nonspecific suppression of primary cultures was at least  50%,  the mean 
percent difference was 54.9% in the secondary MLR  assay and 63.7% in the secondary 
CML  assay. When  the percent  nonspecific suppression  in  the primary MLR  assay 
was 28.8%,  33.4%, and 41.3%, the specificity difference in the secondary MLR  assay 
was  10.6%,  6.8%,  and  34.1%,  respectively.  Similarly, when  the  percent  nonspecific 
suppression  of  the  primary  CML  assay  was  26.5%,  30.2%,  and  37.8%,  then  the 
specificity difference  in  the  secondary  CML  assay  was  15.8%,  27~7%,  and  21.9%, 
respectively. 
Nonspecific  Inhibition  of [aH]Thymidine  Incorporation in  the  PrimaTy MLR  by  Newborn 
BALB/c Spleen Cells.  Spleen cells from newborn BALB/c mice were co-cultured with 
equal  numbers  of normal  adult  responder  and  stimulator  cells  from  a  variety  of 
strains. Spleen cells from adult BALB/c mice were used as co-cultured cell controls. 
Six experiments were performed using 2- or 3-d-old newborn BALB/c mice, and one 
representative result is shown in Table VII. Newborn (2 or 3 d  after birth) spleen cells 532  SUPPRESSOR  CELLS  AFTER  TOTAL  LYMPHOID  IRRADIATION 
TAaLE  VII 
Nonspecific Inhibition of the MLR by Newborn Spleen Cells 
Responder  Stimulator  Co-cultured  [aH]Thymidine in-  Percent 
cells*  cells:[:  cells§  corporation  (mean  suppres- 
cpm +  SD)  sion[[ 
BALB  BALB  BALB  5,186 ::1:568 
BALB  C57  BALB  100,998 ±  3,119 
BALB  C57  NB¶  42,101 :tz 948 
C57  C57  C57  2,479 ±  467 
C57  BALB  BALB  51,770 ±  1,446 
C57  BALB  NB  16,872 ±  762 
C3H  C3H  C3H  5,803 ::lz 923 
C3H  C57  BALB  100,764 ::1:5,895 
C3H  C57  NB  37,945 +  1,037 
BALB  BALB  BALB  5,186 ±  568 
BALB  C3H  BALB  97,075 ±  5,993 
BALB  C3H  NB  36,076 ±  2,392 
C57  C57  C57  2,479 ±  467 
C57  C3H  BALB  44,372 ±  7,568 
C57  C3H  NB  12,193 ±  2,307 
C3H  C3H  C3H  5,803 ::1:923 
C3H  BALB  BALB  104,571  ±  4,819 
C3H  BALB  NB  45,482 ±  2,657 
* 5 ×  105 responder cells per well were used. 
58.3 
67.4 
62.3 
62.8 
72.5 
56.5 
:~ 5 ×  105 stimulator cells per well were given 3,000 rad in vitro. 
§ 5 ×  105 co-cultured cells per well were given 1,500  rad in vitro. 
I] Percent  suppression =  (1  -  [(cpm  with  NB  co-cultured  cells)/(cpm  with 
BALB co-cultured cells)]) x  100. 
¶ Newborn BALB/c donors (3 d after birth). 
suppressed the MLR by 55-90% with a mean of 71% as compared with adult spleen 
cells.  Thus, the pattern of inhibition of the MLR was similar to that observed with 
cells from TLI-treated donors, in that no specificity for responder or stimulator cells 
was seen in any of the strain combinations. 
Discussion 
We have previously shown that potent nonspecific suppressor cells of the MLR and 
of graft-vs.-host disease are present in the spleens of adult BALB/c mice immediately 
after TLI, and gradually disappear during the subsequent 3-4 wk (11). The present 
study confirms and extends this work. Spleen cells obtained from BALB/c mice within 
the first 1-2 wk after TLI suppressed the MLR by 55-95% regardless of the strain of 
origin of the responder or stimulator cells. Similarly, the generation of cytolytic cells 
in  MLR cultures were suppressed  by 50-90%.  It is unlikely that  the suppression is 
mediated by natural killer (NK) cells, as NK activity of spleen cells from mice given 
TLI was similar to cells from normal donors (A. Oseroff and S. Strober, unpublished 
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Recently, several investigators have reported that antigen-specific and nonspecific 
suppressor cells are generated in MLR cultures along with cytolytic cells (29-42).  To 
determine the effect  of spleen  cells  from TLI-treated donors on the generation of 
suppressor cells in the MLR, primary bulk MLR cultures containing  normal responder 
cells, normal stimulator cells, and co-cultured cells obtained from either TLI-treated 
or untreated donors were  allowed to incubate for 6  d. At the end of the primary 
culture period, the cells were irradiated (1,500 rad) and added to a secondary MLR 
culture. The secondary cultures were assayed for both suppression  of [aH]thymidine 
incorporation and generation of cytolytic cells. Antigen specificity of suppression  was 
tested by comparing the effect of cells from primary cultures on secondary cultures in 
which the secondary stimulator cells were either syngeneic or allogeneic to the primary 
stimulator cells. Haplotype restriction of suppression  was tested by comparing the 
effect of cells from primary cultures on secondary cultures in which the secondary 
responder cells were either syngeneic or allogeneic to the primary responder cells. 
Cells from primary cultures in which responder, stimulator, and co-cultured cells 
were all syngeneic (all obtained from normal adult BALB/c donors) generally showed 
little suppression of [aH]thymidine incorporation or generation of cytolytic cells in the 
secondary MLR cultures.  However, primary cultures containing normal  BALB/c 
responder cells, normal C57BL/Ka stimulator cells, and normal BALB/c co-cultured 
cells markedly suppressed  [3H]thymidine incorporation and the generation ofcytolytic 
cells regardless  of the  source  of responder  and  stimulator cells  in  the  secondary 
cultures.  Thus, the suppressor cells generated in the primary cultures under the latter 
conditions were antigen nonspecific,  and were not restricted by the major histocom- 
patibility complex haplotype of the responders in the secondary euhures. It is unlikely 
that  the  nonspecific  suppression  of the  secondary cultures was  due  to  killing of 
secondary responder or stimulator cells by cytolytic cells generated in the primary 
cultures, as cells from primary cultures suppressed secondary cultures in which neither 
the secondary responder nor stimulator cells were syngeneic to the stimulator cells in 
the primary cultures. 
Although fresh  spleen  cells from TLI-treated BALB/e mice nonspecifically sup- 
pressed  primary MLR cultures, their suppressive  activity disappeared after several 
days  of in  vitro  incubation  with  BALB/c  responder  and  stimulator  cells. Cells 
harvested from such syngeneic primary cultures failed to show suppressive  activity 
after addition to secondary allogeneic  MLR cultures. On the other hand, cells from 
primary cultures containing normal BALB/c responders,  normal C57BL/Ka stimu- 
lators,  and  co-cultured  cells  from  primary  cultures  containing  normal  BALB/c 
responders,  normal C57BL/Ka stimulators, and co-cultured cells from BALB/c mice 
given TLI strongly suppressed secondary cultures only when the secondary stimulator 
cells were syngeneic to the primary stimulator cells. These antigen-specific suppressor 
cells were not restricted by the haplotype of  the secondary responder cell, as suppressive 
activity was about equal whether or not the secondary responder was syngeneic or 
allogeneic to the primary responder. 
It is unlikely that antigen-specific suppression  observed in secondary cultures was 
caused by specific killing of secondary stimulator cells by cytolytic cells generated in 
primary cultures containing cells from TLI-treated donors.  In several  experiments 
with marked suppression  (~90%)  of the generation of cytolytic cells in the primary 
cultures, no cytolysis above background was produced by primary cells at effector/ 534  SUPPRESSOR  CELLS AFTER TOTAL LYMPHOID IRRADIATION 
target ratios of 1:4. However, marked suppression of the secondary MLR and CML 
assays was observed with the same primary cells at a primary cell/secondary stimulator 
cell ratio of 1:4. In addition, the primary cells (BALB X C57 X TLI) failed to inhibit 
the MLR or CML responses of C57BL/Ka cells to BALB/c stimulators at the same 
concentrations  that  inhibited  secondary cultures  with  C57BL/Ka  stimulators  (S. 
Okada and S. Strober, unpublished observations). 
It  is  of interest  that  the  magnitude  of nonspecific suppression  of the  primary 
cultures by spleen cells from TLI-treated mice was directly proportional to the degree 
of antigen  specificity  of the  suppressor  cells  of the  secondary  cultures.  In  those 
experiments in which primary cultures were minimally suppressed by the addition of 
spleen cells from TLI-treated mice, there was minimal specificity of suppression in the 
secondary cultures (considerable suppression with all combinations of responders and 
stimulators). 
A hypothesis derived from previous reports (29-41) that explains the data above is 
that responder cells in the MLR, in the absence of co-cultured cells from TLI-treated 
mice, generate at least three types of cells:  cytolytic cells, nonspecific suppressor cells, 
and antigen-specific suppressor cells (see Fig.  1). Spleen cells from TLI-treated mice 
inhibit the generation of the cytolytic cells and nonspecific suppressor cells, but  do 
not  inhibit  the  generation of antigen-specific suppressor cells.  Because  nonspecific 
suppressor cells generated in the primary cultures can "mask" the specific suppressor 
cells, the latter cells are not ordinarily observed in primary cultures.  However, the 
addition of spleen cells from TLI-treated mice "unmasks" the antigen-specific sup- 
pressors. Spleen cells obtained from neonatal mice within  2-3  d  of birth show the 
same pattern of nonspecific inhibition of the MLR as observed with cells from TLI- 
treated mice (Table VII).  In addition, the neonatal cells show a  similar pattern of 
inhibition  of the  generation  of cytolytic and  nonspecific suppressor  cells  without 
blocking the generation of specific suppressor cells. ~ 
In  all  of the experiments with secondary cultures described above, the primary 
cultures  were  made  up  such  that  the  co-cuhured  cells  were  syngeneic  with  the 
responder cells. To determine whether spleen cells from TLI-treated mice have similar 
regulatory effects on allogeneic responder cells in primary cultures, normal C57BL/ 
Ka responder cells and normal BALB/c stimulator cells were co-cultured with cells 
from TLI-treated BALB/c mice. A similar pattern of nonspecific suppression of the 
primary  cultures  and  antigen-specific  suppression  of the  secondary  cultures  was 
observed. However, optimum suppression of secondary cultures occurred only when 
the  secondary responder and  stimulator  combination  was  identical  to  that  in  the 
primary culture. Thus, antigen-specific suppression could not be mediated by specific 
killing of secondary stimulator cells. 
In  conclusion, spleen cells  from TLI-treated mice can  inhibit  the  generation  of 
cytolytic cells and nonspecific suppressor cells in the MLR when the responder cell is 
either syngeneic or allogeneic to the co-cultured cells.  However, these spleen cells do 
not  inhibit  the  generation of antigen-specific suppressor cells.  The overall effect is 
that allogeneic stimulator cells in the presence of cells from TLI-treated or neonatal 
Okada, S., and S. Strober. Spleen cells from adult mice given total lymphoid irradiation or from 
newborn mice have similar regulatory effect in the mixed leukocyte  reaction. II. Generation of antigen- 
specific suppressor cells in the MLR after the addition of spleen cells from newborn mice. Manuscript 
submitted for publication. SHIGEKI  OKADA  AND  SAMUEL  STROBER  535 
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FIc.  1.  Regulatory Cell Model. In the two-party MLR culture containing normal responder ceils 
and normal stimulator cells (irradiated in vitro) (A),  the responder cells generate cytolytic cells, 
antigen-nonspecific suppressor cells, and perhaps antigen-specific suppressor cells masked by anti- 
gen-nonspecific suppressor cells.  After the addition of spleen cells  from adult mice given TLI or 
from newborn mice, the generation of cytolytic cells  and nonspeeific suppressor cells  is blocked. 
However, the generation of antigen-specific suppressor cells (B) proceeds without impairment. Thus, 
continued alloantigen stimulation produces a pool of antigen-specific suppressor cells which continue 
to block the generation of cytolytic cells. The latter pool may play an important role in maintaining 
tolerance in vivo even after the nonspecific suppressor cells  found after TLI or in newborn mice 
disappear. 
mice tend to stimulate the production of large numbers of antigen-specific suppressor 
cells rather than cytolytic cells. This regulatory phenomenon may render these mice 
highly susceptible  to tolerance induction in vivo for short periods of time after birth 
or radiotherapy. 
Summary 
We  added  spleen  cells  from  adult  BALB/c mice  treated  with  total  lymphoid 
irradiation (TLI) to the mixed leukocyte reaction (MLR) using a variety of responder 
and stimulator cells. The spleen  cells nonspeeifically suppressed  the uptake of [aH]- 
thymidine and the generation of cytolytic ceils regardless of the responder-stimulator 
combination used. We also examined the effect of the spleen cells on the generation 
of antigen-nonspeeific and antigen-specific suppressor  cells in the MLR. The experi- 
mental results suggest that the spleen cells from TLI-treated mice inhibit the gener- 
ation of nonspecific  suppressor  cells, but do not inhibit the generation of antigen- 
specific suppressor  cells. Thus, alloantigenic stimulation of normal responder cells in 
vitro in the presence of spleen cells from TLI-treated mice generates large numbers of 536  SUPPRESSOR  CELLS AFTER TOTAL LYMPHOID IRRADIATION 
antigen-specific suppressor cells, but few cytolytic cells or nonspecific suppressor cells. 
Similar  nonspecific inhibition  of the MLR  was observed with neonatal  spleen  cells. 
This in vitro system provides a  regulatory model for the induction and maintenance 
of tolerance in vivo, in which adult mice given TLI or neonatal mice accept allogeneic 
bone marrow transplants without graft-vs.-host disease. 
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